TWIST BIOSCIENCE CORP (1TWST.MI) Stock Price, Forecast & Analysis
Europe - BIT:1TWST - US90184D1000 - Common Stock
1TWST.MI Key Statistics, Chart & Performance
The current stock price of 1TWST.MI is 29.49 EUR.
1TWST.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ARGX.BR | ARGENX SE | 71.58 | 47.33B | ||
| 1AE.DE | ARGENX SE | 72.42 | 47.89B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 21.69B | ||
| 2X1.DE | ABIVAX SA | N/A | 7.07B | ||
| ABVX.PA | ABIVAX SA | N/A | 6.96B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.79B | ||
| 5CV.DE | CUREVAC NV | 5.3 | 1.04B | ||
| NANO.PA | NANOBIOTIX | N/A | 860.16M | ||
| PHIL.MI | PHILOGEN SPA | 20.44 | 681.29M | ||
| IVA.PA | INVENTIVA SA | N/A | 468.94M | ||
| FYB.DE | FORMYCON AG | N/A | 367.54M | ||
| VLA.PA | VALNEVA SE | N/A | 342.29M |
Related stock screener links
About 1TWST.MI
Company Profile
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 923 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The company has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The firm also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The firm's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. The company has minority ownership in Atlas Data Storage, Inc.
Company Info
TWIST BIOSCIENCE CORP
681 Gateway Blvd.
South San Francisco CALIFORNIA US
Employees: 923
Phone: 18007190671
TWIST BIOSCIENCE CORP / 1TWST.MI FAQ
Can you describe the business of TWIST BIOSCIENCE CORP?
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 923 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The company has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The firm also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The firm's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. The company has minority ownership in Atlas Data Storage, Inc.
What is the stock price of TWIST BIOSCIENCE CORP today?
The current stock price of 1TWST.MI is 29.49 EUR. The price increased by 37.42% in the last trading session.
What is the dividend status of TWIST BIOSCIENCE CORP?
1TWST.MI does not pay a dividend.
What is the ChartMill technical and fundamental rating of 1TWST stock?
1TWST.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Should I buy 1TWST stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1TWST.MI.
What is the market capitalization of 1TWST stock?
TWIST BIOSCIENCE CORP (1TWST.MI) has a market capitalization of 1.78B EUR. This makes 1TWST.MI a Small Cap stock.
Can you provide the upcoming earnings date for TWIST BIOSCIENCE CORP?
TWIST BIOSCIENCE CORP (1TWST.MI) will report earnings on 2025-11-14, before the market open.
1TWST.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1TWST.MI.
1TWST.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 1TWST.MI. 1TWST.MI has a great financial health rating, but its profitability evaluates not so good.
1TWST.MI Financial Highlights
Over the last trailing twelve months 1TWST.MI reported a non-GAAP Earnings per Share(EPS) of -1.95. The EPS increased by 41.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.24% | ||
| ROE | -17.81% | ||
| Debt/Equity | 0 |
1TWST.MI Forecast & Estimates
16 analysts have analysed 1TWST.MI and the average price target is 37.25 EUR. This implies a price increase of 26.31% is expected in the next year compared to the current price of 29.49.
For the next year, analysts expect an EPS growth of 58.82% and a revenue growth 20.55% for 1TWST.MI